CLASS II Drug recall · Reported 30 Mar 2022 · FDA Enforcement Report
NAD+ Nicotinamide Adenine Dinucleotide recalled
Olympia Compounding Pharmacy is recalling NAD+ Nicotinamide Adenine Dinucleotide, Lyophilized powder for reconstitution, Multi-Dose, distributed nationwide in the US. The recall was initiated on 8 Mar 2022 and the FDA has classified it as Class II.
Check your package
Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.
Recall details
- Recall number
- D-0719-2022
- FDA event ID
- 89717
- Recalling firm
- Olympia Compounding Pharmacy, Orlando, FL
- Classification
- Class II
- Status
- Terminated
- Recall initiated
- 8 Mar 2022
- FDA classified
- 29 Mar 2022
- Reported
- 30 Mar 2022
- Type
- Voluntary: Firm initiated
- Customers notified by
- Letter
- Reason category
- Sterility
- Drug class
- Injectable & IV Drugs
Timeline
| 8 Mar 2022 | Recall initiated by company | |
| 29 Mar 2022 | Classified by FDA | +21 days |
| 30 Mar 2022 | Published in enforcement report | +1 day |
Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.
Reason for recall
Product found to be Sub Potent or Exceeded reconstitution time
A sterility recall means a product that must be sterile, such as an injection or eye drop, may be contaminated. Using a non-sterile product can cause serious infection.
Product as listed by the FDA
NAD+ Nicotinamide Adenine Dinucleotide, Lyophilized powder for reconstitution, Multi-Dose 500 mg per vial, Each ML contains: 0.288% Sodium Phosphate Monobasic USP, 0.42% Sodium Phosphate Dibasic USP, 5% Mannitol USP, Sterile Water for Injection USP, Rx Only, Olympia Pharmaceuticals 6700 Conroy Rd., Ste. 155, Orlando, FL 32835 NDC: 73198-0083-00
Where it was distributed
Nationwide in the USA including Puerto Rico.
Questions about this recall
Is NAD+ Nicotinamide Adenine Dinucleotide, Lyophilized powder for reconstitution, Multi-Dose recalled?
Yes. Olympia Compounding Pharmacy recalled NAD+ Nicotinamide Adenine Dinucleotide, Lyophilized powder for reconstitution, Multi-Dose on 8 Mar 2022. The recall is Class II and its status is Terminated. Recall number D-0719-2022.
Why was it recalled?
Product found to be Sub Potent or Exceeded reconstitution time
Which lots are affected?
Lot: D24005 Exp. 4/5/22; C41008 Exp. 3/8/22
Where was it sold?
Nationwide in the USA including Puerto Rico.
What should I do if I have it?
Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.
What does Class II mean?
Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.
Read the official FDA notice · Source record retrieved 21 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.
More recalls from Olympia Compounding Pharmacy
All 94| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Sermorelin Acetate Lyophilized powder recalled | Olympia Compounding Pharmacy | Sterility | Nationwide |
| Drug | CLASS II | Lipo-Mino-Mix Pyridoxine HCL recalled by Olympia Compounding Pharmacy | Olympia Compounding Pharmacy | Sterility | Nationwide |
| Drug | CLASS II | Zinc Chloride 5 mg/mL), Multi-Dose vial recalled | Olympia Compounding Pharmacy | Sterility | Nationwide |
| Drug | CLASS II | NAD+ Nicotinamide Adenine Dinucleotide recalled | Olympia Compounding Pharmacy | Sterility | Nationwide |
| Drug | CLASS II | Testosterone Cypionate 200 mg/mL in Sesame Oil recalled | Olympia Compounding Pharmacy | Sterility | Nationwide |